11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Queen Elizabeth Hospital Birmingham · University of Birmingham
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate…
Citation impact
- FWCI
- 26.67
- Percentile
- 100%
- References
- 428
Authors
8- JTJeremy TomlinsonCorresponding
Queen Elizabeth Hospital Birmingham, University of Birmingham
- EAElizabeth A. Walker
Queen Elizabeth Hospital Birmingham, University of Birmingham
- IBIwona Bujalska
Queen Elizabeth Hospital Birmingham, University of Birmingham
- NDNicole Draper
Queen Elizabeth Hospital Birmingham, University of Birmingham
- GGGareth G. Lavery
Queen Elizabeth Hospital Birmingham, University of Birmingham
Topics & keywords
- Dehydrogenase
- Nicotinamide adenine dinucleotide phosphate
- Nicotinamide adenine dinucleotide
- 11β-hydroxysteroid dehydrogenase type 1
- Cortisone
- Glucocorticoid
- Flavin adenine dinucleotide
- Cofactor
- Good health and well-being